YOUR BUSINESS AUTHORITY
Springfield, MO
Loxo Oncology Inc. and Bayer are collaborating to develop and commercialize two cancer drugs.
The deal could bring the U.S. drug developer up to $1.55 billion.
Loxo will receive a $400 million upfront payment, followed by incentive payments for milestones.
Read more from RTT News.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach